...
首页> 外文期刊>Journal of Medicinal Chemistry >Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors
【24h】

Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors

机译:细胞溶质HSP90抑制剂效力的热力学解剖和选择性

获取原文
获取原文并翻译 | 示例

摘要

The cytosolic Hsp90-selective inhibitor TAS-116 has an acceptable safety profile and promising antitumor activity in clinical trials. We examined the binding characteristics of TAS-116 and its analogs to determine the impact of the ligand binding mode on selectivity for cytosolic Hsp90. Analyses of the co-crystal structure of Hsp90 and inhibitor TAS-116 suggest that TAS-116 interacts with the ATP-binding pocket, the ATP lid region, and the hydrophobic pocket. A competitive isothermal titration calorimetry analysis confirmed that a small fragment of TAS-116 (THS-510) docks into the lid region and hydrophobic pockets without binding to the ATP-binding pocket. THS-510 exhibited enthalpy-driven binding to Hsp90 alpha and selectively inhibited cytosolic Hsp90 activity. The heat capacity change of THS-510 binding was positive, likely due to the induced conformational rearrangement of Hsp90. Thus, we concluded that interactions with the hydrophobic pocket of Hsp90 determine potency and selectivity of TAS-116 and derivatives for the cytosolic Hsp90 isoform.
机译:细胞溶质Hsp90选择性抑制剂TAS-116在临床试验中具有可接受的安全性和良好的抗肿瘤活性。我们研究了TAS-116及其类似物的结合特性,以确定配体结合模式对胞质Hsp90选择性的影响。对Hsp90和抑制剂TAS-116共晶结构的分析表明,TAS-116与ATP结合囊、ATP盖区和疏水囊相互作用。竞争性等温滴定量热分析证实,TAS-116(THS-510)的一小部分对接到盖子区域和疏水袋中,而不与ATP结合袋结合。THS-510表现出与Hsp90α的焓驱动结合,并选择性地抑制细胞溶质Hsp90活性。THS-510结合的热容变化为正,可能是由于诱导的Hsp90构象重排。因此,我们得出结论,与Hsp90疏水囊的相互作用决定了TAS-116及其衍生物对胞质Hsp90亚型的效力和选择性。

著录项

  • 来源
    《Journal of Medicinal Chemistry 》 |2021年第5期| 共9页
  • 作者单位

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Univ Tokyo Inst Med Sci Tokyo 1088639 Japan;

    Univ Tokyo Dept Bioengn Grad Sch Engn Tokyo 1138656 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Taiho Pharmaceut Co Ltd CMC Div Chem Technol Lab Kamikawamachi Saitama 3670241 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Taiho Pharmaceut Co Ltd Formulat Res CMC Div Tokushima 7710194 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Taiho Pharmaceut Co Ltd Discovery &

    Preclin Res Div Tsukuba Ibaraki 3002611 Japan;

    Univ Tokyo Dept Bioengn Grad Sch Engn Tokyo 1138656 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号